RACHEL TOSH: Open Payments
NPI 1124772587 · BOLIVAR, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$761 in 30 payments from 18 companies in 2025. Trend: 2023 $0 · 2024 $174 · 2025 $761
Food & beverage: $661Education: $100
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 5 | $190 |
| SANOFI-AVENTIS U.S. LLC | 1 | $100 |
| E.R. Squibb & Sons, L.L.C. | 5 | $89 |
| Janssen Biotech, Inc. | 3 | $54 |
| Exelixis Inc. | 3 | $52 |
| Aveo Pharmaceuticals, Inc. | 1 | $32 |
| Merck Sharp & Dohme LLC | 1 | $30 |
| GENZYME CORPORATION | 1 | $24 |
| Pacira Pharmaceuticals Incorporated | 1 | $23 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $22 |
Products named: SARCLISA, CABOMETYX, OPDIVO, IMFINZI, FOTIVDA, LYNPARZA, CARVYKTI, Exparel.
Industry payments across TN — which companies pay providers there.
